Press release
Sarcopenia Market is expected to show positive growth, during the forecast period of 2019 to 2032, DelveInsight
Sarcopenia Market
Sarcopenia Overview
Sarcopenia is a condition which is characterized by loss of muscle mass, muscle strength and functional muscle impairment with ageing. The definition has been through various alterations. However, an enormous recent breakthrough is the inclusion of the condition in the ICD-10 classification of diseases. The physical consequences of this disease put a person at risk for falls, fractures, and hospitalization, thereby affecting the quality of life and death in extreme cases.
Download a Sample Copy of the Market Report- https://www.delveinsight.com/sample-request/sarcopenia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Highlights of the Sarcopenia Market Report
• As per Society on Sarcopenia, Cachexia and Wasting Disorders, the prevalence of Sarcopenia ranges from 15% at 65 years to 50% at 80 years in humans, with normal aging associated with a 1-2% muscle loss beyond the age of 50 years.
• As per DelveInsight estimates, the total prevalent population of Sarcopenia in the 7MM was found to be 33,321,576 in 2017.
• According to DelveInsight, males are affected more as compared to females in case of Sarcopenia.
Sarcopenia Epidemiology Insights
Current definitions of Sarcopenia are only newly developed and still not entirely accepted. Reported prevalence rates of Sarcopenia vary significantly due to differing definitions, tools of diagnosis, and patient populations. Estimates range from 10% in individuals >65 years of age, rising to 30% in men over 80.
Sarcopenia Epidemiology Segmentation in the 7MM
• Sarcopenia Prevalent Cases
• Sarcopenia Prevalence by Gender
Sarcopenia Etiology
The etiology of sarcopenia is a constellation of factors involving the aging neuromuscular machinery (motor unit number and efficiency, muscle architecture and orientation, fiber type distribution), reduced anabolic hormone levels, muscle disuse, and inflammation, driven by environmental, genetic and behavioral factors.
Sarcopenia Treatment
Drugs designed to treat sarcopenia are now starting to emerge. When considering the patients selected to enter studies of novel therapies to prevent or retard the development of sarcopenia, it is helpful to be aware of the industry regulatory processes surrounding drug development. Besides, the IOF has published recommendations specifically addressing the conduct of sarcopenia clinical trials and suggested possible trial endpoints and selection criteria for individuals who might participate in such studies.
Sarcopenia Treatment Market
Nutritional supplementation, resistance training, exercise, vibrational therapy constitute the treatment space for sarcopenia. Compared with singular interventions, combined interventions, including comprehensive exercise-based treatment interventions, such as resistance training and nutritional intervention, are effective for improving sarcopenia and are recommended.
Sarcopenia Market Insights
Assessment of the effect of interventions in research and clinical practice is required to enable them to be targeted appropriately. Unfortunately, no clear consensus has yet been reached regarding which intermediate measures should be used in research settings or clinical guidelines. The dynamics of sarcopenia market is anticipated to experience a positive shift in the coming years owing to the expected launch of BIO101 (Biophytis) and Bimagrumab (Novartis).
Do you know how the Sarcopenia market will grow by 2030? Click to get in-depth detail of the report- https://www.delveinsight.com/report-store/sarcopenia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Sarcopenia Market Drivers
• Better insights into disease intervention
• Increase in research initiatives
• Need for a cost-effective therapy
Sarcopenia Market Barriers
• Need for screening tools
• Implementation of interventions
• Diagnosis associated shortcomings
Sarcopenia Market Companies
• Biophytis
• Novartis
• Eli Lily
• Immunoforge
• Regeneron Pharmaceuticals
• Sanofi, and several others
Request Sample Report- https://www.delveinsight.com/sample-request/sarcopenia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Key Insights
2. Sarcopenia Executive Summary
3. Competitive Intelligence Analysis for Sarcopenia
4. Sarcopenia Market Overview at a Glance
5. Sarcopenia Disease Background and Overview
6. Patient Journey
7. Sarcopenia Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Sarcopenia Unmet Needs
10. Key Endpoints of Sarcopenia Treatment
11. Sarcopenia Marketed Products
12. Sarcopenia Emerging Therapies
13. Sarcopenia: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Sarcopenia Market Outlook
16. Access and Reimbursement Overview
17. KOL Views
18. Sarcopenia Market Drivers
19. Sarcopenia Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
23. About DelveInsight
Sarcopenia Market Report Highlights
• In the coming years, the Sarcopenia market is set to change due to the rising awareness of the disease, and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market
• The companies and academics are working to assess challenges and seek opportunities that could influence Sarcopenia R&D. The therapies under development are focused on novel approaches to treat/improve the disease condition
• Major players are involved in developing therapies for Sarcopenia. The launch of emerging therapies will significantly impact the Sarcopenia market
• A better understanding of disease pathogenesis will also contribute to the development of novel therapeutics for Sarcopenia
• Our in-depth analysis of the pipeline assets across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities
Why should you buy this report?
• The report will help in developing business strategies by understanding trends shaping and driving the Sarcopenia market
• To understand the future market competition in the Sarcopenia market and Insightful review of the key market drivers and barriers
• Organize sales and marketing efforts by identifying the best opportunities for Sarcopenia in the US, Europe (Germany, Spain, Italy, France, and the United Kingdom) and Japan
• Identification of strong upcoming players in the market will help in devising strategies that will help in getting ahead of competitors
• Organize sales and marketing efforts by identifying the best opportunities for Sarcopenia market
• To understand the future market competition in the Sarcopenia market
Do you have any query related to the report? If yes, visit here- https://www.delveinsight.com/report-store/sarcopenia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Contact Us
Yash
info@delveinsight.com
About Us
DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Sarcopenia Market is expected to show positive growth, during the forecast period of 2019 to 2032, DelveInsight here
News-ID: 2698604 • Views: …
More Releases from DelveInsight Business Research
Global Patient Engagement Solutions Market to reach USD 59,499.28 million by 203 …
According to DelveInsight's analysis, The growth of the patient engagement solutions market is primarily fueled by several major factors, including the increasing burden of chronic conditions such as diabetes and cardiovascular diseases, which require continuous patient involvement and monitoring. The industry is further propelled by the move toward patient-centric healthcare models, ongoing technological innovations, and the introduction of new digital tools and platforms. Moreover, supportive government policies and initiatives aimed…
Global Magnetic Resonance Imaging Devices Market to reach USD 13,553.33 million …
According to DelveInsight's analysis, The growing incidence of chronic illnesses-including heart disease, cancer, and neurological disorders is driving demand for advanced diagnostic methods such as MRI, which provides highly detailed imaging of soft tissues and internal organs. Increasing awareness and a stronger focus on early disease detection are also prompting both patients and healthcare professionals to rely on MRI for faster and more accurate diagnosis. In addition, ongoing technological progress…
Global Microbial Fermentation Technology Market Size was USD 33,956.10 million i …
According to DelveInsight's analysis, The microbial fermentation technology market is experiencing strong growth, largely due to the increasing incidence of chronic illnesses such as cancer and a range of infectious diseases, including HIV, hepatitis B and C, and influenza. The market is also being boosted by the rising need for advanced therapeutic products like cell therapies, monoclonal antibodies, recombinant proteins, and gene therapies. Moreover, progress in synthetic biology and precision…
Global Surgical Robotic System Market to reach USD 29,785.13 million by 2032 at …
According to DelveInsight's analysis, The growing prevalence of chronic illnesses such as cancer, cardiovascular diseases, and orthopedic disorders is driving demand for advanced surgical solutions, which in turn is accelerating the expansion of the surgical robotic systems market. Since many of these conditions require complex, highly precise procedures, robotic-assisted surgery is becoming a preferred option due to its superior precision, less invasive nature, and faster patient recovery. At the same…
More Releases for Sarcopenia
Sarcopenia Market Size, Share & Growth Analysis 2034
Sarcopenia Market Overview
Sarcopenia is a condition characterized by the progressive loss of muscle mass, strength, and function, primarily affecting the elderly. This decline leads to increased frailty, higher risk of falls, and diminished quality of life. The rising global geriatric population has heightened the prevalence of sarcopenia, making it a significant public health concern. Consequently, there is a growing demand for effective treatments and interventions to manage and mitigate the…
Sarcopenia Treatment Market Future Prediction Report By 2030
Sarcopenia Treatment Market business research report assesses the current as well as upcoming performance of the market, also brand-new trends in the market. It provides product overview and highlights of product and application segments of the market including price, revenue, sales, sales growth rate, and market share by product. The market statistics within the report is displayed in a statistical format to offer a better understanding upon the market dynamics.…
Sarcopenia Treatment Market Report 2024 - Sarcopenia Treatment Market Size And G …
"The Business Research Company recently released a comprehensive report on the Global Sarcopenia Treatment Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
According to The Business Research Company's, The sarcopenia treatment market…
Sarcopenia Pipeline Insights Report 2023 (Updated)
(Albany, United States) As per DelveInsight's assessment, globally, the Sarcopenia Pipeline constitutes 8+ key companies continuously working towards developing 10+ Sarcopenia Pipeline treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analysis DelveInsight.
In the Sarcopenia Pipeline Report, a detailed description of the drug is given which includes the mechanism of action of the drug, clinical studies, Sarcopenia NDA approvals (if any), and product…
Global Sarcopenia Therapeutic Market Research Report 2023
The global Sarcopenia Therapeutic market was valued at US$ 2867.6 million in 2022 and is anticipated to reach US$ 3484.4 million by 2029, witnessing a CAGR of 3.3% during the forecast period 2023-2029.
view full report
https://reports.valuates.com/market-reports/QYRE-Auto-13K14453/global-sarcopenia-therapeutic
Sarcopenia Therapeutic Market
Sarcopenia is a syndrome caused by continuous loss of skeletal muscle mass, strength, and function.
The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
China is the largest consumption region of…
Sarcopenia - Drug Pipeline Landscape, 2022
Sarcopenia is a condition characterized by the loss of muscle mass and strength. It can occur due to a variety of reasons, including aging, inactivity, and certain chronic diseases.
Aging is the most common cause of sarcopenia. As people age, they tend to become less active and lose muscle mass. This process is known as age-related muscle loss or sarcopenia with aging.
Inactivity can also lead to sarcopenia. People who are not…
